Multiple Electrolytes Injection (II) and Normal Saline on Hyperchloremia in Severe Hemorrhagic Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 342 participants.
Also called NCT06374823
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 342 participants
- Sponsor
- Registry
-
NCT06374823
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06374823. Randomized; no masking; primary purpose treatment. Start 2024-05 (anticipated); primary completion 2026-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Multiple Electrolytes Injection (II) and Normal Saline on Hyperchloremia in Severe Hemorrhagic Stroke
- Acronym
- MERIT
- Condition
- Critical Care
- Condition
- Hyperchloremia
- Condition
- Hemorrhagic Stroke
- Intervention (Drug)
- Multiple Electrolyte
- Intervention (Drug)
- Normal Saline
- Lead sponsor
- Capital Medical University
Record details
- Record id
cardio:ct-nct06374823- Content hash
a066977a9fbe7adb72acf3ca3f3da0fffcdc9d2a647b4352bdb8779dd1012be7